Sonneveld MJ - Search Results

1

Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.

Zoutendijk R, Zaaijer HL, de Vries-Sluijs TE, Reijnders JG, Mulder JW, Kroon FP, Richter C, van der Eijk AA, Sonneveld MJ, Hansen BE, de Man RA, van der Ende ME, Janssen HL. Zoutendijk R, et al. Among authors: sonneveld mj. J Infect Dis. 2012 Sep 15;206(6):974-80. doi: 10.1093/infdis/jis439. Epub 2012 Jul 10. J Infect Dis. 2012. PMID: 22782950

2

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Polaris Observatory Collaborators. Polaris Observatory Collaborators. Lancet Gastroenterol Hepatol. 2023 Oct;8(10):879-907. doi: 10.1016/S2468-1253(23)00197-8. Epub 2023 Jul 27. Lancet Gastroenterol Hepatol. 2023. PMID: 37517414

3

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.

Sonneveld MJ, Janssen HL. Sonneveld MJ, et al. Curr Hepat Rep. 2010 May;9(2):91-98. doi: 10.1007/s11901-010-0041-7. Epub 2010 Apr 15. Curr Hepat Rep. 2010. PMID: 20461129 Free PMC article.

4

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline.

Sonneveld MJ, Rijckborst V, Boucher CA, Hansen BE, Janssen HL. Sonneveld MJ, et al. Hepatology. 2010 Oct;52(4):1251-7. doi: 10.1002/hep.23844. Hepatology. 2010. PMID: 20830787 Clinical Trial.

5

Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.

Reijnders JG, Rijckborst V, Sonneveld MJ, Scherbeijn SM, Boucher CA, Hansen BE, Janssen HL. Reijnders JG, et al. Among authors: sonneveld mj. J Hepatol. 2011 Mar;54(3):449-54. doi: 10.1016/j.jhep.2010.07.046. Epub 2010 Nov 5. J Hepatol. 2011. PMID: 21112655 Clinical Trial.

6

Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?

Sonneveld MJ, Janssen HL. Sonneveld MJ, et al. Liver Int. 2011 Jan;31 Suppl 1:78-84. doi: 10.1111/j.1478-3231.2010.02384.x. Liver Int. 2011. PMID: 21205142 Review.

7

A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.

Sonneveld MJ, Rijckborst V, Boucher CA, Zwang L, Beersma MF, Hansen BE, Janssen HL. Sonneveld MJ, et al. J Clin Virol. 2011 Jul;51(3):175-8. doi: 10.1016/j.jcv.2011.04.005. Epub 2011 May 17. J Clin Virol. 2011. PMID: 21592855 Free article.

8

Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.

Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL. Sonneveld MJ, et al. Gastroenterology. 2012 Mar;142(3):513-520.e1. doi: 10.1053/j.gastro.2011.11.025. Epub 2011 Nov 19. Gastroenterology. 2012. PMID: 22108195

9

Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?

Janssen HL, Sonneveld MJ, Brunetto MR. Janssen HL, et al. Among authors: sonneveld mj. Gut. 2012 May;61(5):641-5. doi: 10.1136/gutjnl-2011-301096. Epub 2011 Dec 16. Gut. 2012. PMID: 22180061 Review. No abstract available.

10

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.

Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL. Sonneveld MJ, et al. Antivir Ther. 2012;17(1):9-17. doi: 10.3851/IMP1887. Antivir Ther. 2012. PMID: 22267464 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page